Call toll-free 800.328.1267
Biotechnology stocks are ripping in 2019, fueled by some high-profile takeovers. It was only the second trading session of the year that Bristol Myers Squibb (BMY) gobbled up Celgene (CELG) in a record $74 billion deal. Loxo Oncology (LOXO) accepted an $8 billion bid...
Disclosure: This post is intended for educational purposes only and should not be considered a recommendation. Options trading may not be suitable for all investors. A massive, high-risk options trade is looking for upside in the takeover-frenzied media space. Here's...
If you've ever wondered about bulls chasing a Fox, look no further than the activity yesterday's options market. And no, we're not talking about a rerun of Downton Abbey. We're talking about the big spike of options activity in media conglomerate Twenty-First Century...